- NRN1 genetic variability and methylation changes as biomarkers for cognitive remediation therapy response in schizophrenia
- Associations between clinical data, vaccination status, antibody responses, and post-COVID-19 symptoms in Thais infected with SARS-CoV-2 Delta and Omicron variants: a 1-year follow-up study
- Introgressive hybridisation puts the distinctive population of Apis mellifera mellifera in Ireland at risk: evidence from a multidisciplinary approach
- Dose and timing effects of caffeine on subsequent sleep: A randomised clinical crossover trial
- PNPLA3 rs738409, environmental factors and liver-related mortality in the US Population
- Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cell in vitro
- Investigating Undiagnosed Fabry Disease in Young Adults with Ischemic Stroke: A Multicenter Cohort Study
- Comparison of Nucleotide MALDI-TOF MS with Xpert MTB/RIF for Rifampicin Susceptibility Identification and Associated Risk Factors of Rifampicin Resistance Among Drug Resistant Mycobacterium tuberculosis
- Association of PPARGC1A gene polymorphism and mtDNA methylation with coal-burning fluorosis: a case–control study
- DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium
Close